Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Immunome Inc’s stock clocked out at $11.45, up 3.43% from its previous closing price of $11.07. In other words, the price has increased by $3.43 from its previous closing price. On the day, 0.85 million shares were traded. IMNM stock price reached its highest trading level at $11.68 during the session, while it also had its lowest trading level at $11.18.
Ratios:
To gain a deeper understanding of IMNM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.49 and its Current Ratio is at 10.49. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on April 02, 2025, initiated with a Buy rating and assigned the stock a target price of $23.
On November 08, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $27 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 03 ’25 when BIENAIME JEAN JACQUES bought 5,000 shares for $9.38 per share. The transaction valued at 46,900 led to the insider holds 36,415 shares of the business.
BIENAIME JEAN JACQUES bought 7,800 shares of IMNM for $60,684 on Mar 25 ’25. The Director now owns 31,415 shares after completing the transaction at $7.78 per share. On Mar 26 ’25, another insider, SIEGALL CLAY B, who serves as the President and CEO of the company, bought 137,100 shares for $7.29 each. As a result, the insider paid 999,459 and bolstered with 806,736 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 996290880 and an Enterprise Value of 683738176. For the stock, the TTM Price-to-Sale (P/S) ratio is 91.07 while its Price-to-Book (P/B) ratio in mrq is 3.24. Its current Enterprise Value per Revenue stands at 62.51 whereas that against EBITDA is -3.891.
Stock Price History:
The Beta on a monthly basis for IMNM is 1.93, which has changed by -0.28571427 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, IMNM has reached a high of $16.81, while it has fallen to a 52-week low of $5.15. The 50-Day Moving Average of the stock is 27.49%, while the 200-Day Moving Average is calculated to be 15.60%.
Shares Statistics:
It appears that IMNM traded 1.02M shares on average per day over the past three months and 1015930 shares per day over the past ten days. A total of 86.96M shares are outstanding, with a floating share count of 76.80M. Insiders hold about 11.74% of the company’s shares, while institutions hold 82.36% stake in the company. Shares short for IMNM as of 1751241600 were 12580117 with a Short Ratio of 12.38, compared to 1748563200 on 13239384. Therefore, it implies a Short% of Shares Outstanding of 12580117 and a Short% of Float of 15.100000999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
